Combining GE imaging technology with Elekta treatment solutions
The global ultrasound market was estimated at $8.5 billion in 2023
First used on January 27, 1968
Will install at five cancer centers across the UK
Automatically plans treatments for complex parts of the body
Research found that adaptive filters can increase image quality while reducing CT radiation.
Better comprehension of tumor response and normal-tissue toxicity
CT dose is on the Institute's 2010 list of top 10 technology hazards.
Incorporates plastic scintillation detectors developed by Medscint
SAH Global signs UK bank subsidiary for its $150 million center in Qatar.
Axonics has accused Medtronic of trying to stifle competition
Technology and infrastructure issues that hospitals need to be aware of
Reduces radiation exposure by up to 84%
The National Cancer Institute extended its cooperative group agreement with the Radiation Therapy Oncology Group.
The NEMA group representing manufacturers of imaging equipment cautions that new U.S. Food and Drug Administration clearance delays could slow outfitting devices with features to reduce radiation dose to patients.
Adds JenaValve for aortic regurgitation, Endotronix for heart failure management solutions
American College of Radiology says "political elements" crept into FDA meeting to discuss ways to protect patients and practitioners from the dangers of medical radiation.
Will provide advanced simulation facilities with hands-on training tailored to various medical professionals
The world's first CT to image the entire heart and cardiovascular system in a single heartbeat
Will develop next-generation radiopharmaceutical pipeline candidates
The Wexner Medical Center has worked with Siemens-owned Varian for nearly a decade
ARRT board of trustees appoints new members
Radiation Therapy Oncology Group (RTOG) gains clinical leader; New Director of Protocol Development and Regulatory Compliance also named.
Ohio Valley Surgical Hospital appoints CEO
Meeting will focus on CT, fluoroscopy safety.
Molecular radiotherapy offers hope for children with relapsed or primary refractory neuroblastoma.
Interface will integrate proton therapy into existing radiation therapies.
New research unveiled at ASTRO
